SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5ยข to $5 -- Ignore unavailable to you. Want to Upgrade?


To: RikRichter who wrote (73827)4/25/2008 10:27:01 AM
From: RikRichter  Respond to of 120411
 
Lonza settles legal dispute with Northwest Biotherapeutics on GS Gene products
04.24.08, 3:04 AM ET

FRANKFURT (Thomson Financial) - Lonza Group AG. said Northwest Biotherapeutics Inc. agreed to destroy the GS Gene Expression system materials, made by Lonza, in its possession to end a legal dispute.

The GS Gene Expression System, owned and licensed by Lonza, is used to make therapeutic recombinant proteins and monoclonal antibodies.

maria.sheahan@thomsonreuters.com

Copyright Thomson Financial News Limited 2008. All rights reserved.